Condition: Prostate Cancer, Localized Malignant Neoplasm

Study Type: Observational

Clinical Trials Identifier NCT 8-digits: NCT01766492

Sponsor: Georgetown University

Phase:

Eligibility:

• Age: minimum 18 Years maximum 99 Years
• Gender: Male

Inclusion Criteria:

• Histologically confirmed adenocarcinoma of prostate
• Signed study-specific consent
• Prostate Specific Antigen (PSA) within 60 days of registration

Exclusion Criteria:

• Prior pelvic radiotherapy
• Prior radical prostate surgery
• Medical or psychiatric illness that would interfere with treatment or follow up
• Implanted hardware adjacent to the prostate that would prohibit appropriate treatment planning and/or treatment delivery

View trial on ClinicalTrials.gov